Overabundant Species, Explained: When Microbes Crowd Out the Rest

REVIEWED BY

William Maish, MD MBA MPH

Clinical Product Lead

Published

Last updated

Key takeaway:

This overabundant species test identifies microbial species present at unusually high levels to pinpoint microbiome imbalances. That information can guide targeted interventions that may help reduce risks of digestive disturbances, recurrent infections, and chronic inflammation.

Read more →

Understand what your gut health results really mean

See your biomarkers in context with a comprehensive panel.

  • CLIA-certified labs
  • HIPAA compliant
  • Personalized health protocol
Book your test

Flagging microbes that are crowding out the rest

The overabundant species test pinpoints bacterial and fungal groups with unusually high relative abundance. Results highlight “who’s too loud in the room,” flagging species or genera that dominate beyond typical reference ranges for a healthy, diverse gut community. Because microbiomes evolve with diet, medications, and stress, this test reflects your current ecosystem rather than a fixed trait.

Why dominance matters more than any one species

Why this matters: your gut microbes help digest fiber into short-chain fatty acids, shape immune tone, train the gut barrier, and even influence metabolic and mood signaling through the gut–brain axis. When one or a few taxa swell beyond their neighbors, functions can skew — think excess gas production, altered bile acid recycling, or more inflammatory signaling. While the science continues to mature, consistent patterns emerge: more diversity is generally linked with resilience, and dominance by a narrow cast of microbes often tracks with symptoms or instability.

Day to day, your microbiome is like a city that runs on shared jobs. Different microbial “neighborhoods” ferment fiber, produce vitamins, reinforce the mucus barrier, and break down bile. When one group grows outsized, it can crowd out helpful neighbors and tilt the city’s economy. The overabundant species test connects that biology to real-life questions: Why the sudden bloating after antibiotics? Could your recent ultra-processed stretch be feeding gas-producing microbes? Are you seeing more skin flares or food-triggered discomfort after a restrictive diet? By mapping relative abundance against reference populations, the test helps identify dysbiosis patterns that can accompany digestive symptoms, immune reactivity, and metabolic shifts.

Join 150,000+ others building better health

Get the science behind better health, every week.

By clicking “Subscribe” you agree to our Terms of Service and Privacy Policy.

When to reach for this view of the microbiome

It’s particularly useful after big inflection points — a course of antibiotics, a major diet change, new supplements, travel, a GI infection, or persistent symptoms that haven’t resolved. Overabundance of certain pathobionts (microbes that can be friendly in moderation but problematic in excess) may point to lower short-chain fatty acid output, higher histamine or lipopolysaccharide exposure, or reduced butyrate producers that support the gut barrier. For context, larger cohort studies associate higher microbial diversity with metabolic flexibility and lower inflammatory tone, though specifics vary and ongoing research is refining the details. This test won’t diagnose disease and it won’t locate small-intestinal overgrowth directly (stool reflects the colon, and breath testing assesses the small intestine). It’s a snapshot, based on relative — not absolute — counts, and results can differ across labs because of sequencing methods and databases. Used alongside your history and other biomarkers, it becomes a practical compass rather than a verdict.

Test 100+ biomarkers from home

One blood draw. A full picture of your health, explained in plain language.

Book your test

Reading a dominance report

Your report shows which species or genera are disproportionately high compared with reference ranges. It typically summarizes relative abundance, diversity metrics, and functional clues — for example, whether gas producers or mucin degraders occupy more space than is typical for a stable gut community. “Balanced” profiles tend to feature higher diversity and healthy representation of beneficial genera like Bifidobacterium and Faecalibacterium.

When the ecosystem is balanced, you’re more likely to see efficient fiber fermentation with robust short-chain fatty acid production (butyrate, acetate, propionate), steadier immune signaling, and a well-supported gut barrier. Optimal patterns vary by person, geography, and diet, but stability and diversity are the recurring themes.

When imbalance appears, you may see lower diversity with one or a few taxa dominating. That pattern can align with symptoms such as gas, urgency, constipation, or food-triggered discomfort, or with an ecosystem recovering from antibiotics or infection. These findings aren’t a diagnosis — they’re functional signposts that can inform nutrition strategies, prebiotic discussions, or medical evaluation if symptoms persist.

Where an overabundant species test helps — and where it doesn't

Big picture, this test is most informative when viewed over time and alongside other markers such as fecal calprotectin (gut inflammation), serum metabolic labs, or immune panels. Keep in mind that recent antibiotics, colonoscopy prep, probiotics, and acute illness can shift results; collection variability and lab methods also influence readouts. Interpreted in context, the overabundant species test helps personalize your path toward steadier digestion, energy, and resilience.

Frequently Asked Questions

References

  1. Falony G, Joossens M, Vieira-Silva S, Wang J, Darzi Y, Faust K, Kurilshikov A, Bonder MJ, Valles-Colomer M, Vandeputte D, Tito RY, Chaffron S, Rymenans L, Verspecht C, De Sutter L, Lima-Mendez G, D'hoe K, Jonckheere K, Homola D, Raes J (2016). Population-level analysis of gut microbiome variation. *Science*, *352*(6285), 560-564. https://doi.org/10.1126/science.aad3503
  2. Afzaal M, Saeed F, Shah YA, Hussain M, Rabail R, Socol CT, Hassoun A, Pateiro M, Lorenzo JM, Rusu AV, Aadil RM (2022). Human gut microbiota in health and disease: Unveiling the relationship. *Frontiers in Microbiology*, *13*, 999001. https://doi.org/10.3389/fmicb.2022.999001
  3. Fusco W, Lorenzo MB, Cintoni M, Porcari S, Rinninella E, Kaitsas F, Lener E, Mele MC, Gasbarrini A, Collado MC, Cammarota G, Ianiro G (2023). Short-chain fatty-acid-producing bacteria: Key components of the human gut microbiota. *Nutrients*, *15*(9), 2211. https://doi.org/10.3390/nu15092211
  4. Jovel J, Patterson J, Wang W, Hotte N, O'Keefe S, Mitchel T, Perry T, Kao D, Mason AL, Madsen KL, Wong, G. K.-S. (2016). Characterization of the gut microbiome using 16S or shotgun metagenomics. *Frontiers in Microbiology*, *7*, 459. https://doi.org/10.3389/fmicb.2016.00459
  5. Drago L (2025). Navigating microbiome variability: Implications for research, diagnostics, and direct-to-consumer testing. *Frontiers in Microbiology*, *16*, 1580531. https://doi.org/10.3389/fmicb.2025.1580531

Led by doctors with 40 years of health and longevity expertise

Dr. Anant Vinjamoori

Dr. Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Dr. Leigh Erin Connealy

Dr. Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Dr. Robert Lufkin

Dr. Robert Lufkin, MD

Physician & UCLA Medical School Professor, NYT bestselling author

Dr. Abe Malkin

Dr. Abe Malkin, MD

Founder & Medical Director of Concierge MD

Membership 1
1 / 4

Your membership starts here

Annual 100+ biomarker panel

  • Data dashboard and digital twin
  • Upload past labs and connect wearables
  • Personalized health protocol
  • 24/7 care team access
  • AI companion for all health questions
  • Marketplace with additional solutions
$199
/year*Billed annually
Get started
HSA/FSA eligibleCancel anytimeResults in a week

*Pricing may vary for members in New York and New Jersey